Zydus Cadila Seeks DCGI Nod for Human Clinical Trials of Antibodies Cocktail to Treat Covid-19
3 years, 6 months ago

Zydus Cadila Seeks DCGI Nod for Human Clinical Trials of Antibodies Cocktail to Treat Covid-19

News 18  

Zydus Cadila on Thursday said it is seeking permission from Drugs Controller General of India to initiate human clinical trials for monoclonal antibodies cocktail for treatment of COVID-19. “Zydus is currently seeking permission to initiate phase 1/3 human clinical trials from the DCGI… ZRC-3308, a cocktail of two SARS-CoV-2-neutralizing monoclonal antibodies can emerge as one of the main treatments for mild COVID 19,” Cadila Healthcare said in a regulatory filing. Zydus said it is the only Indian company to have developed a neutralizing monoclonal antibody based cocktail for the treatment of COVID-19. Earlier this week, drug majors Roche India and Cipla announced the launch of Roche’s Antibody Cocktail in India priced at Rs 59,750 per dose for the treatment of mild to moderate COVID-19 in patients who are at high risk.

India Treatment Treat Zydus Human Clinical Trials Dcgi Nod Zrc Cadila Healthcare  seeking  trials  healthcare  clinical  human  zrc3308  treatments  zydus  dcgi  nod  india  seeks  treat  treatment  covid19  cadila  monoclonal  cocktail

History of this topic

DCGI Approves Market Authorisation for SII's Covid Vaccine Covovax as Heterologous Booster Dose
1 year, 11 months ago

DCGI Approves Market Authorisation for SII's Covid Vaccine Covovax as Heterologous Booster Dose

News 18  

The Drug Controller General of India has approved market authorisation to COVID-19 vaccine Covovax as a heterologous booster dose for adults who have been administered two doses of Covishield or Covaxin, official sources said on Monday. Prakash Kumar Singh, Director of Government and Regulatory Affairs at the Serum Institute of India, had recently written to the DCGI for the approval …

Covid-19: India's first intranasal vaccine by Bharat Biotech gets DCGI approval
2 years, 3 months ago

Covid-19: India's first intranasal vaccine by Bharat Biotech gets DCGI approval

India TV News  

The Bharat Biotech on Tuesday got emergency use authorisation from the Drugs Controller General of India for the Intranasal Covid-19 vaccine. Union Minister of Health and Family Welfare Mansukh Mandaviya termed it a 'Big boost' to India's fight against Covid-19. Bharat Biotech's ChAd36-SARS-CoV-S COVID-19 recombinant nasal vaccine approved by CDSCO_INDIA_INF for primary immunization against COVID-19 in 18+ age group for …

Bharat Biotech Nasal Covid Vaccine's Phase 3 Trials Completed
2 years, 6 months ago

Bharat Biotech Nasal Covid Vaccine's Phase 3 Trials Completed

News 18  

Bharat Biotech on Saturday said that the clinical Phase III trials of the nasal vaccine for Covid-19 have been completed and that the company will submit its data with Drugs Controller General of India next month. Dr Krishna Ella, Chairman and Managing Director of Bharat Biotech on Saturday said, if everything is okay, then they will get permission to launch …

Zydus Gets DCGI Nod for Drug to Treat Anaemia Associated with Chronic Kidney Disease
2 years, 9 months ago

Zydus Gets DCGI Nod for Drug to Treat Anaemia Associated with Chronic Kidney Disease

News 18  

Zydus Lifesciences on Monday said it has received an approval from the Drug Controller General of India for Oxemia, a first-of-its-kind oral treatment for anaemia associated with chronic kidney disease. “There was a potential for an oral, safer alternative to currently available injectable erythropoietin-stimulating agents,” Zydus Lifesciences Chairman Pankaj R Patel noted. “This advancement offers ease of convenience for the …

Houston COVID-19 vaccine Corbevax gets DCGI approval for use in India
2 years, 11 months ago

Houston COVID-19 vaccine Corbevax gets DCGI approval for use in India

Firstpost  

The vaccine uses an older recombinant protein yeast fermentation technology similar to that used for the recombinant hepatitis B vaccine which has been around for 40 years. Our vaccine technology offers a path to address an unfolding humanitarian crisis, namely the vulnerability the low- and middle-income countries face against the delta variant,” said Dr Peter Hotez, professor and dean of …

Centre places purchase order for one crore doses of Zydus Cadila’s Covid vaccine
3 years, 1 month ago

Centre places purchase order for one crore doses of Zydus Cadila’s Covid vaccine

Live Mint  

Zydus Cadila's three-dose Covid vaccine ZyCoV-D is set to be included in the national anti-coronavirus inoculation programme this month with the Centre placing a purchase order with the Ahmedabad-based firm for one crore doses, official sources said on Sunday. "The Centre has already placed a purchase order with Zydus Cadila for supply of one crore doses of ZyCoV-D, each costing …

Merck’s Molnupiravir, Glenmark’s Nasal Spray, Zydus' Antibody Cocktail: 20+ Drugs in Pipeline for Covid
3 years, 2 months ago

Merck’s Molnupiravir, Glenmark’s Nasal Spray, Zydus' Antibody Cocktail: 20+ Drugs in Pipeline for Covid

News 18  

Merck’s Molnupiravir, Zydus’ antibody cocktail and Glenmark’s nasal spray are among more than 20 new drugs in different stages of drug trials or approvals in India to treat Covid-19. “As the world needs Covid-19 vaccines, the world also needs proven and effective Covid-19 therapies,” Lahariya said. List of Drugs in the Pipeline US pharma giant Merck and Ridgeback Biotherapeutics’ oral …

Covid Vaccine For Kids Soon? Govt to Make Zydus Cadila's 3-dose Jab Part of National Drive
3 years, 2 months ago

Covid Vaccine For Kids Soon? Govt to Make Zydus Cadila's 3-dose Jab Part of National Drive

News 18  

Zydus Cadila?s Covid-19 DNA vaccine will be?introduced? On August 20, DCGI approved Zydus Cadila vaccine for emergency use in adults and children aged 12 years and above. LIVE Updates At the weekly health ministry briefing, Health Secretary Rajesh Bhushan said:?Zydus vaccine will be introduced very soon. Last week, responding to a question at a press conference, NITI Aayog Member Dr …

Zydus Cadila Covid vaccine to be part of national vaccination programme soon: Health Ministry
3 years, 2 months ago

Zydus Cadila Covid vaccine to be part of national vaccination programme soon: Health Ministry

India Today  

The health ministry has said that Zydus Cadila's Covid-19 vaccine would be introduced in the national vaccination programme very shortly. Union health secretary Rajesh Bhushan said, “Zydus Cadila vaccine has been given approval. We are in conversation with the manufacturers about the pricing of the vaccine.” “Since it is a 3-dose vaccine, it would have differential pricing than the currently …

UK to roll out life-saving COVID-19 treatment which was given to Donald Trump
3 years, 3 months ago

UK to roll out life-saving COVID-19 treatment which was given to Donald Trump

India TV News  

Thousands of vulnerable health service patients in the UK hospitals due to COVID-19 are set to benefit from a life-saving new antibody treatment called Ronapreve, which was given to former US president Donald Trump. “We have secured a brand new treatment for our most vulnerable patients in hospitals across the UK and I am thrilled it will be saving lives …

Zydus Cadila's Covid vaccine ZyCoV-D launch likely in October: Sources
3 years, 3 months ago

Zydus Cadila's Covid vaccine ZyCoV-D launch likely in October: Sources

India TV News  

Zydus Cadila's needle-free coronavirus vaccine ZyCoV-D is likely to be launched in early October, according to sources. Indigenously developed Zydus Cadila's ZyCoV-D had received approval for Emergency Use Authorisation from the drug regulator two weeks ago, making it the first vaccine in the country which would be administered in the age group of 12-18 years. On the kind of negotiations …

DCGI nod to phase-I clinical trial of COVID-19 vaccine of Reliance Life Sciences
3 years, 3 months ago

DCGI nod to phase-I clinical trial of COVID-19 vaccine of Reliance Life Sciences

The Hindu  

The Drugs Controller General of India on September 3 granted permission to the Mukesh Ambani-owned Reliance Life Sciences to conduct phase-I clinical trial of its indigenous COVID-19 vaccine with certain conditions, sources said. The phase-I clinical trial will be conducted to evaluate safety, tolerability and immunogenicity of the SARS-CoV-2 recombinant protein subunit vaccine in healthy volunteers according to protocol, they …

Biological E's ‘Corbevax’ gets DCGI approval for two clinical trials
3 years, 3 months ago

Biological E's ‘Corbevax’ gets DCGI approval for two clinical trials

Hindustan Times  

The Drugs Controller General of India has given approval to Biological E for two clinical trials of its Covid-19 vaccine candidate Corbevax, the ministry of science and technology announced Friday. The Hyderabad-based pharmaceutical company received approval for Phase 3 comparator safety and immunogenicity trial in adults after a review of Phase 1 and 2 clinical trials data by a subject …

NTAGI to Meet This Week to Introduce Zycov-D in Covid-19 Immunisation Plan
3 years, 3 months ago

NTAGI to Meet This Week to Introduce Zycov-D in Covid-19 Immunisation Plan

News 18  

The National Technical Advisory Group on Immunisation will hold a key meet this week to outline the roadmap for the introduction of DNA-based Zydus Cadila’s vaccine in the general population. It is expected that the meet will help prepare a plan on how to inculcate and introduce the Zycov-D vaccine in India’s immunisation programme. The official added that adolescents with …

Zydus Cadila to start making 1 crore doses of Covid vaccine by October
3 years, 4 months ago

Zydus Cadila to start making 1 crore doses of Covid vaccine by October

India Today  

Zydus Cadila announced on Saturday that they will start producing one crore doses of Covid-19 vaccine by October. When asked about the government projection that there would be five crore doses of Zydus Cadila vaccine in August, Dr Sharvil Patel, Managing Director of Zydus Cadila, said, “We faced a delay of 45 days to commission the new plant,” and added, …

Zydus Cadila Becomes 6th Weapon in India's Armour Against Covid
3 years, 4 months ago

Zydus Cadila Becomes 6th Weapon in India's Armour Against Covid

News 18  

Indigenously developed Zydus Cadila Covid-19 vaccine ZyCoV-D on Friday received Emergency Use Authorisation from the Drug Controller General of India. Johnson & Johnson Johnson & Johnson’s single-dose COVID-19 vaccine has been given Emergency Use approval in India, Union Health minister Mansukh Mandaviya said. Johnson and Johnson’s single-dose COVID-19 vaccine is given approval for Emergency Use in India. The SII is …

Zydus Cadila's 3-dose Jab Approved; India Gets its First Vaccine for Children 12 Years and Above
3 years, 4 months ago

Zydus Cadila's 3-dose Jab Approved; India Gets its First Vaccine for Children 12 Years and Above

News 18  

Indian drug regulator DCGI on Friday approved Zydus Cadila’s three-dose COVID-19 DNA vaccine for emergency use in adults and children aged 12 years and above, bringing in the sixth vaccine authorized for use in the country. After news of the approval, Prime Minister Narendra Modi and Union Health Minister Mansukh Mandaviya lauded India’s fight against Covid-19, with another weapon in …

Zydus Cadila's 3-dose Covid Vaccine ZyCov-D Gets Govt Panel Nod
3 years, 4 months ago

Zydus Cadila's 3-dose Covid Vaccine ZyCov-D Gets Govt Panel Nod

News 18  

The Indian drug regulator?s subject expert committee has recommended emergency use approval for Zydus Cadila?s three-dose COVID-19 vaccine. The generic drugmaker, listed as Cadila Healthcare Ltd, applied for the authorisation of the vaccine ZyCoV-D on July 1, based on an efficacy rate of 66.6% in a late-stage trial of more than 28,000 volunteers nationwide. Zydus Cadila had earlier said that …

COVID-19 vaccines for children will arrive 'very soon', says Mansukh Mandaviya
3 years, 4 months ago

COVID-19 vaccines for children will arrive 'very soon', says Mansukh Mandaviya

Firstpost  

AIIMS Director Dr Randeep Guleria recently said data of phase two and three trials of Bharat Biotech’s Covaxin on 2 to 18 years age group is expected by September Ahmedabad: Union Health Minister Mansukh Mandaviya on Thursday said results of ongoing research for the development of COVID-19 vaccines for children may arrive next month and the antidote may be launched …

Zydus Cadila's Covid vaccine gets emergency use nod, will be first jab for 12-18 year olds
3 years, 4 months ago

Zydus Cadila's Covid vaccine gets emergency use nod, will be first jab for 12-18 year olds

India Today  

Vaccine maker Zydus Cadila's three-dose Covid vaccine ZyCoV-D has got DCGI approval for emergency use authorisation. The Subject Expert Committee of Central Drugs Standard Control Organisation had recommended an emergency use authorization for Zydus Cadila's three-dose Covid-19 vaccine, ZyCoV-D. ZyCoV-D is a three-dose, intradermal vaccine, which is applied using a needle-free system, Tropis, which can also lead to a significant …

Regeneron: Covid-19 antibody treatments work, but they’re ‘not the path out of this pandemic’
3 years, 4 months ago

Regeneron: Covid-19 antibody treatments work, but they’re ‘not the path out of this pandemic’

CNN  

CNN — When Texas Gov. Monoclonal antibodies such as those made by Regeneron and GlaxoSmithKline won’t work for every Covid-19 patient; mAbs, as they are known, are only available for people age 12 and older and who aren’t hospitalized or severely ill. Regeneron’s therapy can also be used for some people who know they were exposed to the virus,but don’t …

Zydus Cadila's Covid vaccine to get Govt's approval this week: Report
3 years, 4 months ago

Zydus Cadila's Covid vaccine to get Govt's approval this week: Report

India TV News  

Zydus Cadila Vaccine News: The Government is likely to give its nod for emergency use authorisation to Zydus Cadila's needle-free Covid-19 vaccine 'ZyCoV-D' this week, news agency ANI reported on Monday. 'ZyCoV-D' will be a three-dose vaccine and the companys plans to manufacture 10-12 crore doses annually, Zydus Cadila had said in a statement last month. Last week, Union Health …

Zydus Cadila vaccine may get nod this week, will be first jab for 12-18 year olds
3 years, 4 months ago

Zydus Cadila vaccine may get nod this week, will be first jab for 12-18 year olds

India Today  

The Covid vaccine candidate of Zydus Cadila is likely to get emergency use authorisation from the Centre this week, sources told India Today. The company has conducted the largest clinical trial for its Covid-19 vaccine in India, including on the adolescent population in the 12-18 years age group. If approved, ZyCoV-D would be the first vaccine in India for the …

Patients unable to produce Covid antibodies supported by new drug
3 years, 4 months ago

Patients unable to produce Covid antibodies supported by new drug

NL Times  

The Erasmus Medical Center has begun using the drug REGEN-Cov to treat patients with Covid-19 who have a reduced ability to produce antibodies themselves. “You are buying time for patients to make their own antibodies”, said Bart Rijnders, an internist and infectious diseases specialist at the hospital. “In patients who will never produce their own antibodies, it helps the other …

Biocon Biologics Gets Licence from Adagio Therapeutics for Antibody Treatment of Covid-19
3 years, 4 months ago

Biocon Biologics Gets Licence from Adagio Therapeutics for Antibody Treatment of Covid-19

News 18  

Biocon Biologics, a subsidiary of Biocon, on Monday said it has got a licence from US-based Adagio Therapeutics for an antibody therapy to treat and prevent COVID-19, for India and select markets. Adagio Therapeutics has granted an exclusive licence to the company to manufacture and commercialise an antibody treatment based on ADG20 for India and select emerging markets, Biocon Biologics …

Zydus Cadila to Submit Additional Data on Covid Vaccine to DGCI This Week: Sources
3 years, 5 months ago

Zydus Cadila to Submit Additional Data on Covid Vaccine to DGCI This Week: Sources

News 18  

The Gujarat-based pharma company Zydus Cadila is expected to provide additional data related to immunogenicity and safety of its vaccinate candidate ZyCoV-D to the Drugs Controller General of India this week, according to sources. Zydus’ three-dose vaccine was reported to be 66.6 per cent effective against symptomatic Covid cases and 100 per cent effective for moderate infection. NITI Aayog member …

Zydus Cadila has applied for approval, Bio-E's Covid vaccine to enter market by October: Health Minister
3 years, 5 months ago

Zydus Cadila has applied for approval, Bio-E's Covid vaccine to enter market by October: Health Minister

India Today  

Zydus Cadila has applied for Emergency Use Authorisation for its Covid-19 vaccine, Union Health Minister Mansukh Mandaviya told Rajya Sabha on Tuesday. In his first speech in the Rajya Sabha as Union Health Minister, Mansukh Mandaviya also said that there is hope that vaccinations for children will begin soon. We are procuring 11-12 crore doses of AstraZeneca's Covishield from the …

Zydus Cadila’s Covid vaccines for children may be available soon: Govt to court
3 years, 5 months ago

Zydus Cadila’s Covid vaccines for children may be available soon: Govt to court

Live Mint  

Indian drugmaker Zydus Cadila's Covid-19 vaccine may be available for children in the 12 to 18 age group soon, the central government has told Delhi High Court. "Zydus Cadila has concluded its trial for children between the age group of 12 to 18 and is subject to statutory permissions," the Centre said in an affidavit submitted on Friday. Further, the …

Zydus Cadila's Covid vaccine for 12-18 year olds soon, clinical trials done: Centre to Delhi HC
3 years, 5 months ago

Zydus Cadila's Covid vaccine for 12-18 year olds soon, clinical trials done: Centre to Delhi HC

India Today  

The Centre informed the Delhi High Court that Zydus Cadila has concluded the clinical trial of its DNA-based Covid-19 vaccine ZyCoV-D for the 12-18 age group and that it could soon be available. In an affidavit dated July 15, Satyendra Singh, Under Secretary to the Ministry of Health and Family Welfare, said, "It is submitted that Zydus Cadila which is …

Sanofi, GSK get nod for phase 3 trial of covid-19 vaccine in India
3 years, 5 months ago

Sanofi, GSK get nod for phase 3 trial of covid-19 vaccine in India

Live Mint  

French pharmaceutical Sanofi and its British partner GlaxoSmithKline on Thursday said they have received the approval of the drugs controller general of India to conduct part of the global phase-3 efficacy trial of their jointly developed covid-19 vaccine in India. We believe our covid-19 adjuvanted, recombinant vaccine can make a significant contribution to the ongoing fight against covid-19 and are …

Decision on Zydus needle-free Covid vaccine in few days. What you need to know
3 years, 5 months ago

Decision on Zydus needle-free Covid vaccine in few days. What you need to know

Live Mint  

Ahmadabad-based drugmaker Zydus Cadila's application for the emergency use authorization of its Covid-19 vaccine will likely be taken up by a Subject Expert Committee of India's drug regulator this week, reported news agency Reuters, citing an Economic Times report. The company had last week submitted an application to the Drugs Controller General of India, seeking authorisation for its ZyCoV-D three-dose …

Zydus Cadila seeks Emergency Use Authorisation for its Covid-19 vaccine ZyCoV-D in India
3 years, 5 months ago

Zydus Cadila seeks Emergency Use Authorisation for its Covid-19 vaccine ZyCoV-D in India

India TV News  

Zydus Cadila has applied for Emergency Use Authorisation nod from the Drugs Controller General of India for the launch of its DNA vaccine, ZyCoV-D, for 12 years and above. If DGCA grants approval, ZyCoV-D will join Serum Institute of India's Covishield, Bharat Biotech's Covaxin and Russia's Sputnik V vaccines to be authorized for emergency use in India. The company said …

Zydus Cadila seeks emergency use nod for covid vaccine, also tested in 12-18 year-olds
3 years, 5 months ago

Zydus Cadila seeks emergency use nod for covid vaccine, also tested in 12-18 year-olds

Live Mint  

Zydus Cadila today announced that the company has applied for Emergency Use Authorization to the office of Drug Controller General of India for ZyCoV-D - its Plasmid DNA vaccine against COVID-19. This was also the first time that any COVID-19 vaccine has been tested in adolescent population in the 12-18 years age group in India. As the first ever plasmid …

'Needle-free' Zydus Cadila vaccine to come with an applicator. Company to roll out 5 crore doses by year-end
3 years, 5 months ago

'Needle-free' Zydus Cadila vaccine to come with an applicator. Company to roll out 5 crore doses by year-end

India Today  

The 'needle-free' Zydus Cadila vaccine will come with an applicator, which the company has developed with PharmaJet. A study done with the DNA vaccine between April and June showed a 66% efficacy rate in symptomatic cases, said Sharvil Patel, managing director, Zydus Cadila, There were no cases of death even in moderate to severe cases after the third dose of …

Science behind Zydus Cadila vaccine: Using plasmid DNA platform to fight Covid-19
3 years, 5 months ago

Science behind Zydus Cadila vaccine: Using plasmid DNA platform to fight Covid-19

India Today  

Zydus Cadila on Thursday applied for emergency use authorisation for its Covid-19 vaccine. The company has approached the Drug Controller General of India for a nod to its ZyCoV-D — Plasmid DNA vaccine. As the first-ever plasmid DNA vaccine for human use, ZyCoV-D has proven its safety and efficacy profile in our fight against COVID-19. ZyCoV-D is a plasmid DNA …

Zydus Cadila seeks emergency use nod for its 'needle-free', three-dose vaccine
3 years, 5 months ago

Zydus Cadila seeks emergency use nod for its 'needle-free', three-dose vaccine

India Today  

Zydus Cadila on Thursday announced that the company has applied for Emergency Use Authorization to the office of Drug Controller General of India for ZyCoV-D - its Plasmid DNA Vaccine against Covid-19. This was also the first time that any Covid-19 vaccine has been tested in adolescent population in the 12-18 years age group in India. Whereas, no moderate case …

Covaxin effectively neutralises both Alpha, Delta variants of Covid-19: US' top health institute
3 years, 5 months ago

Covaxin effectively neutralises both Alpha, Delta variants of Covid-19: US' top health institute

India TV News  

India's Covaxin, developed by Bharat Biotech in collaboration with the Indian Council of Medical Research, effectively neutralises both Alpha and Delta variants of coronavirus, the US' National Institute of Health has said. The NIH said results of two studies of blood serum from people who had received Covaxin suggest that the vaccine generates antibodies that effectively neutralise the B.1.1.7 and …

Zydus Cadila may apply for emergency use approval of its Covid vaccine in 7-10 days: Sources
3 years, 6 months ago

Zydus Cadila may apply for emergency use approval of its Covid vaccine in 7-10 days: Sources

India Today  

In a development that could boost India's vaccination drive, Ahmedabad-based vaccine manufacturer Zydus Cadila has told the Centre that it could apply for emergency use authorisation for its Covid-19 vaccine ZyCoV-D in the next seven to ten days, sources privy to the development have told India Today TV. Apart from adults, Zydus Cadila is also conducting trials of its vaccine …

Monoclonal antibody treatment for COVID-19 could be a game changer
3 years, 6 months ago

Monoclonal antibody treatment for COVID-19 could be a game changer

The Hindu  

Monoclonal antibody treatment is now seen as a relatively effective and safer alternative in treating COVID-19 patients, with doctors stating that, as with any other drug, timing is very important for the administration of the therapy that’s touted as a game changer. “Monoclonal antibody treatment could prove to be a game changer in times to come if used at the …

Zydus Cadila to submit application for emergency use authorisation of Covid vaccine in 2 weeks
3 years, 6 months ago

Zydus Cadila to submit application for emergency use authorisation of Covid vaccine in 2 weeks

India Today  

Ahmedabad-based pharmaceutical company Zydus Cadila is likely to submit an application for emergency use authorisation of its Covid-19 vaccine candidate ZyCoV-D to the Drug Controller General of India in two weeks. Zydus Cadila is conducting trials of its vaccine candidate among the 0-18 year age group at present. If approved, ZyCoV-D will be the fourth vaccine to be used in …

No clinical trials required in India for global Covid vaccines: DCGI
3 years, 6 months ago

No clinical trials required in India for global Covid vaccines: DCGI

India TV News  

Globally available Covid 19 vaccines can now be launched in India without the requirement of post approval clinical trials and testing every batch of the vaccine. The Drugs Controller General of India in a notification has said that vaccines which have been approved for restricted use by US FDA, EMA, UK MHRA and PMDA Japan and under the WHO Emergency …

Antibody Cocktail Used to Treat Trump Unlikely to Cause Mutations: Dr Gangakhedkar
3 years, 6 months ago

Antibody Cocktail Used to Treat Trump Unlikely to Cause Mutations: Dr Gangakhedkar

News 18  

Dr Raman Gangakhedkar said on Sunday said Monoclonal antibody cocktail is unlikely to cause further mutations of Covid-19. Dr Gangakhedkar said that in India, pharma company Roche’s antibody cocktail is already being administered to Covid-19 patients with mild infection. The report said that Zydus Cadila has also sought approval for human trials of its antibody cocktail. Dr Gangakhedkar said that …

COVID-19: Cocktail antibodies injection used first time in Andhra Pradesh
3 years, 6 months ago

COVID-19: Cocktail antibodies injection used first time in Andhra Pradesh

India TV News  

Samishta Hospital and Research Institute, Guntur has administered cocktail antibodies injection 'Regeneron' to two patients. This is the first time the cocktail antibodies injection was used in Andhra Pradesh. Chakravarti further said that they have used stem cell therapy on 12 COVID-19 patients. Using stem cell therapy is also giving good results, he said.

Zydus Cadila introduces scratch code in critical drug packs to fight counterfeit menace
3 years, 6 months ago

Zydus Cadila introduces scratch code in critical drug packs to fight counterfeit menace

India Today  

Drug firm Zydus Cadila on Friday said it has introduced a new feature in the packaging of its critical drugs to help patients ensure that the product is not fake or counterfeited. "Counterfeit drugs can be harmful as they may not have the desired outcome and could also be life-threatening in some cases," Cadila Healthcare Managing Director Sharvil Patel noted. …

Zydus Cadila seeks human trial approval for Covid-19 antibody cocktail
3 years, 6 months ago

Zydus Cadila seeks human trial approval for Covid-19 antibody cocktail

India Today  

Zydus Cadila has sought regulatory approval for clinical trials of its antibody cocktail to treat mild Covid-19, as the country grapples with a shortage of medicines and vaccines needed to effectively tackle a devastating second wave of the pandemic. READ: Covid Antibody Cocktail will reduce hospitalisation, can be given to children: Dr Naresh Trehan The therapy is a cocktail of …

Antibody cocktail to treat Covid-19 now in India. What is it? Who should take the therapy?
3 years, 6 months ago

Antibody cocktail to treat Covid-19 now in India. What is it? Who should take the therapy?

India Today  

An 84-year-old man from Haryana, who was the first Covid-19 patient in India to receive an antibody drug cocktail authorised by the Centre earlier this month, has been discharged from hospital. The antibody cocktail shot into the limelight after it was used to treat former United States President Donald Trump last year. The antibody cocktail is to be administered for …

Octogenarian COVID patient who received monoclonal antibody therapy, back home: Hospital
3 years, 6 months ago

Octogenarian COVID patient who received monoclonal antibody therapy, back home: Hospital

India TV News  

An 84-year-old Covid positive man who was given monoclonal antibody therapy in Gurgaon, which is said to reduce the chance of hospitalisation by 70 per cent in patients with mild to moderate symptoms, is back to his home, hospital authorities said on Wednesday. Suffering from COVID-19, Singh is the first patient to receive monoclonal antibody therapy at Medanta, Gurgaon, he …

Zydus Cadila Prices Covid-19 Medicine 'Virafin' at Rs 11,995 Per Dose
3 years, 7 months ago

Zydus Cadila Prices Covid-19 Medicine 'Virafin' at Rs 11,995 Per Dose

News 18  

Days after receiving approval for emergency use of its medicine ‘Virafin’ to treat moderate cases of COVID-19, Zydus Cadila has reportedly pegged the price of the drug at Rs 11,995 per dose. Zydus Cadila has claimed outlined this medicine, technically referred to as Pegylated Interferon alpha-2b, can be given when there is a moderate degree of infection. During the phase …

Zydus announces prices for its Covid drug Virafin approved by DCGI for use in moderate cases
3 years, 7 months ago

Zydus announces prices for its Covid drug Virafin approved by DCGI for use in moderate cases

India Today  

Drug Firm Zydus Cadila has set the price of its medicine ‘Virafin' at Rs 11,995 per dose. After the DCGI's approval for use of this medicine in the treatment of moderate cases of Covid-19, the pharma giant has begun dispatching doses to its vendors. 'Virafin,' a single-use medication obtained emergency use clearance from the Drug Controller General of India, the …

Discover Related